Specific Enhancement of Vascular Endothelial Growth Factor (VEGF) Production in Ischemic Region by Alprostadil : Potential Therapeutic Application in Pharmaceutical Regenerative Medicine

DOI Web Site Web Site PubMed 被引用文献1件 参考文献25件
  • Inoue Hajime
    Department of Plastic and Reconstructive Surgery, St. Marianna University School of Medicine, Japan Department of Stem Cell Therapy (Endowed Chair by ANGFA Co. Japan), St. Marianna University School of Medicine, Japan
  • Aihara Masaki
    Department of Plastic and Reconstructive Surgery, St. Marianna University School of Medicine, Japan
  • Tomioka Miyuki
    Department of Plastic and Reconstructive Surgery, St. Marianna University School of Medicine, Japan
  • Watabe Yu-ichi
    Department of Stem Cell Therapy (Endowed Chair by ANGFA Co. Japan), St. Marianna University School of Medicine, Japan

書誌事項

タイトル別名
  • Specific Enhancement of Vascular Endothelial Growth Factor (VEGF) Production in Ischemic Region by Alprostadil — Potential Therapeutic Application in Pharmaceutical Regenerative Medicine

この論文をさがす

抄録

Alprostadil (lipo-PGE1) is a drug delivery system preparation. This preparation is applied to treat refractory skin ulcers and arteriosclerosis obliterans. We investigated the effects of alprostadil by using the earflap ischemic model. The following results were obtained: 1) Treatment with alprostadil significantly increased the VEGF contents in an ischemic ear; 2) Treatment with alprostadil resulted in strongly expressed VEGF levels only in the ischemic region; 3) Image analysis revealed a significant increase in the number of vessel bypasses and paths after flap creation with alprostadil administration compared to the vehicle-treated ears. The results suggest that it may be possible to apply alprostadil as one device for regenerative medical technology.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (25)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ